S. 1522 · 118th Congress

A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable.

Stage
In committee
Sponsor
Roger Marshall
Introduced
2023-05-10
Latest action
2023-05-10 · Introduced in Senate

Action history

  1. 2023-05-10Introduced in Senate
  2. 2023-05-10Read twice and referred to the Committee on Health, Education, Labor, and Pensions.